ROIV vs. HACAX

In the year-to-date period, ROIV achieves a -10.06% return, which is significantly lower than HACAX's -4.79% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Roivant Sciences Ltd. (ROIV) and Harbor Capital Appreciation Fund Class I (HACAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ROIV Sharpe Ratio is -0.18, which is lower than the HACAX Sharpe Ratio of 0.00. The chart below compares the historical Sharpe Ratios of ROIV and HACAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ROIV nor HACAX has paid dividends to shareholders.

The maximum ROIV drawdown since its inception was -79.22%, which is greater than HACAX's maximum drawdown of -68.72%. Use the drawdown chart below to compare losses from any high point for ROIV and HACAX. For additional features, visit the drawdowns tool.

Roivant Sciences Ltd. (ROIV) has a higher volatility of 10.32% compared to Harbor Capital Appreciation Fund Class I (HACAX) at 8.08%. This indicates that ROIV's price experiences larger fluctuations and is considered to be riskier than HACAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.